Current perspectives of sudden cardiac death management in hypertrophic cardiomyopathy

被引：2

作者：

Pu, Lutong ^{[1
]}

Li, Jialin ^{[1
]}

Qi, Weitang ^{[1
]}

Zhang, Jinquan ^{[2
]}

Chen, Hongyu ^{[2
]}

Tang, Zihuan ^{[2
]}

Han, Yuchi ^{[3
]}

Wang, Jie ^{[1
]}

Chen, Yucheng ^{[1
,4
]}

机构：

[1] Sichuan Univ, West China Hosp, Dept Cardiol, Guoxue Xiang 37, Chengdu 610041, Sichuan, Peoples R China

[2] Sichuan Univ, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China

[3] Ohio State Univ, Coll Med, Wexner Med Ctr, Columbus, OH USA

[4] Sichuan Univ, West China Hosp, Ctr Rare Dis, Chengdu 610041, Sichuan, Peoples R China

来源：

HEART FAILURE REVIEWS | 2024年 / 29卷 / 02期

基金：

中国国家自然科学基金;

关键词：

Hypertrophic cardiomyopathy; Sudden cardiac death; Cardiovascular magnetic resonance; Prognosis; RISK STRATIFICATION; PROGNOSTIC VALUE; GENE-MUTATIONS; PREVENTION; GUIDELINES; CONSEQUENCES; DYSFUNCTION; CARDIOLOGY; SARCOMERE; DIAGNOSIS;

D O I：

10.1007/s10741-023-10355-w

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hypertrophic cardiomyopathy (HCM) is an autosomal dominant disorder characterized by left ventricular hypertrophy. Sudden cardiac death (SCD) is a rare but the most catastrophic complication in patients with HCM. Implantable cardioverter-defibrillators (ICDs) are widely recognized as effective preventive measures for SCD. Individualized risk stratification and early intervention in HCM can significantly improve patient prognosis. In this study, we review the latest findings regarding pathogenesis, risk stratification, and prevention of SCD in HCM patients, highlighting the clinic practice of cardiovascular magnetic resonance imaging for SCD management.

引用

页码：395 / 404

页数：10

共 65 条

[11] The T-peak-to-T-end interval: a novel ECG marker for ventricular arrhythmia and appropriate ICD therapy in patients with hypertrophic cardiomyopathy [J].

Dinshaw, Leon ;

Muench, Julia ;

Dickow, Jannis ;

Lezius, Susanne ;

Willems, Stephan ;

Hoffmann, Boris A. ;

Patten, Monica .

CLINICAL RESEARCH IN CARDIOLOGY, 2018, 107 (02) :130-137

[12] Sudden cardiac death in hypertrophic cardiomyopathy: time to change the narrative [J].

Elliott, Perry .

EUROPEAN HEART JOURNAL, 2021, 42 (38) :3945-3947

[13] 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) [J].

Elliott, Perry M. ;

Anastasakis, Aris ;

Borger, Michael A. ;

Borggrefe, Martin ;

Cecchi, Franco ;

Charron, Philippe ;

Hagege, Albert Alain ;

Lafont, Antoine ;

Limongelli, Giuseppe ;

Mahrholdt, Heiko ;

McKenna, William J. ;

Mogensen, Jens ;

Nihoyannopoulos, Petros ;

Nistri, Stefano ;

Pieper, Petronella G. ;

Pieske, Burkert ;

Rapezzi, Claudio ;

Rutten, Frans H. ;

Tillmanns, Christoph ;

Watkins, Hugh .

EUROPEAN HEART JOURNAL, 2014, 35 (39) :2733-+

[14] Three-dimensional Deep Convolutional Neural Networks for Automated Myocardial Scar Quantification in Hypertrophic Cardiomyopathy: A Multicenter Multivendor Study [J].

Fahmy, Ahmed S. ;

Neisius, Ulf ;

Chan, Raymond H. ;

Rowin, Ethan J. ;

Manning, Warren J. ;

Maron, Martin S. ;

Nezafat, Reza .

RADIOLOGY, 2020, 294 (01) :52-60

[15] Sudden Cardiac Death During Exercise in Young Individuals With Hypertrophic Cardiomyopathy [J].

Finocchiaro, Gherardo ;

Bhatia, Raghav T. ;

Westaby, Joseph ;

Behr, Elijah R. ;

Papadakis, Michael ;

Sharma, Sanjay ;

Sheppard, Mary N. .

JACC-CLINICAL ELECTROPHYSIOLOGY, 2023, 9 (06) :865-867

[16] Arrhythmogenic potential of myocardial disarray in hypertrophic cardiomyopathy: genetic basis, functional consequences and relation to sudden cardiac death [J].

Finocchiaro, Gherardo ;

Sheikh, Nabeel ;

Leone, Ornella ;

Westaby, Joe ;

Mazzarotto, Francesco ;

Pantazis, Antonis ;

Ferrantini, Cecilia ;

Sacconi, Leonardo ;

Papadakis, Michael ;

Sharma, Sanjay ;

Sheppard, Mary N. ;

Olivotto, Iacopo .

EUROPACE, 2021, 23 (07) :985-995

[17] Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice [J].

Fraysse, Bodvael ;

Weinberger, Florian ;

Bardswell, Sonya C. ;

Cuello, Friederike ;

Vignier, Nicolas ;

Geertz, Birgit ;

Starbatty, Jutta ;

Kraemer, Elisabeth ;

Coirault, Catherine ;

Eschenhagen, Thomas ;

Kentish, Jonathan C. ;

Avkiran, Metin ;

Carrier, Lucie .

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2012, 52 (06) :1299-1307

[18] Exercise prescription in individuals with hypertrophic cardiomyopathy: what clinicians need to know [J].

Gati, Sabiha ;

Sharma, Sanjay .

HEART, 2022, 108 (24) :1930-+

[19] Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy [J].

Hegde, Sheila M. ;

Lester, Steven J. ;

Solomon, Scott D. ;

Michels, Michelle ;

Elliott, Perry M. ;

Nagueh, Sherif F. ;

Choudhury, Lubna ;

Zemanek, David ;

Zwas, Donna R. ;

Jacoby, Daniel ;

Wang, Andrew ;

Ho, Carolyn Y. ;

Li, Wanying ;

Sehnert, Amy J. ;

Olivotto, Iacopo ;

Abraham, Theodore P. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (25) :2518-2532

[20] Genotype-Dependent and -Independent Calcium Signaling Dysregulation in Human Hypertrophic Cardiomyopathy [J].

Helms, Adam S. ;

Alvarado, Francisco J. ;

Yob, Jaime ;

Tang, Vi T. ;

Pagani, Francis ;

Russell, Mark W. ;

Valdivia, HCtor H. ;

Day, Sharlene M. .

CIRCULATION, 2016, 134 (22) :1738-1748

← 1 2 3 4 5 6 7 →